BeiGene USA, Inc, based in Cambridge, is a biopharmaceutical company dedicated to developing innovative drug candidates targeting cancer through molecular and immuno-oncology approaches.
The company's primary focus is on advancing therapies that have the potential to transform the treatment landscape for cancer patients, with a commitment to improving outcomes and quality of life.
Generated from their website's infomation